These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2830513)

  • 1. Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate.
    Docampo R; Moreno SN; Cruz FS
    Mol Biochem Parasitol; 1988 Jan; 27(2-3):241-7. PubMed ID: 2830513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet.
    Docampo R; Moreno SN; Gadelha FR; de Souza W; Cruz FS
    Biomed Environ Sci; 1988 Dec; 1(4):406-13. PubMed ID: 3151757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet).
    Docampo R; Moreno SN; Muniz RP; Cruz FS; Mason RP
    Science; 1983 Jun; 220(4603):1292-5. PubMed ID: 6304876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photosensitization by the trypanocidal agent crystal violet. Type I versus type II reactions.
    Reszka K; Cruz FS; Docampo R
    Chem Biol Interact; 1986 May; 58(2):161-72. PubMed ID: 3013436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light.
    Ramirez LE; Lages-Silva E; Pianetti GM; Rabelo RM; Bordin JO; Moraes-Souza H
    Transfusion; 1995 Mar; 35(3):226-30. PubMed ID: 7878715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for prevention of transfusion-associated Chagas' disease.
    Moraes-Souza H; Bordin JO
    Transfus Med Rev; 1996 Jul; 10(3):161-70. PubMed ID: 8809967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrion of Trypanosoma cruzi is a target of crystal violet toxicity.
    Gadelha FR; Moreno SN; De Souza W; Cruz FS; Docampo R
    Mol Biochem Parasitol; 1989 May; 34(2):117-26. PubMed ID: 2540435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for free radical formation during horseradish peroxidase-catalyzed N-demethylation of crystal violet.
    Gadelha FR; Hanna PM; Mason RP; Docampo R
    Chem Biol Interact; 1992 Nov; 85(1):35-48. PubMed ID: 1333891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chagas' disease and blood transfusion: trypanocidal activity of maprotiline hydrochloride and gentian violet].
    Celentano AM; González Cappa SM
    Medicina (B Aires); 1988; 48(3):265-8. PubMed ID: 3150028
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and mode of action of gentian violet.
    Moreno SN
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():308-20. PubMed ID: 3150994
    [No Abstract]   [Full Text] [Related]  

  • 11. A strategy for the prevention of the transmission of Chagas' disease during blood transfusion.
    Hammond DJ; Croft SL; Hogg J; Gutteridge WE
    Acta Trop; 1986 Dec; 43(4):367-78. PubMed ID: 2882664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.
    Chiari E; Oliveira AB; Prado MA; Alves RJ; Galvão LM; Araujo FG
    Antimicrob Agents Chemother; 1996 Mar; 40(3):613-5. PubMed ID: 8851580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-transfusion Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood.
    Moraes-Souza H; Bordin JO; Bardossy L; MacPherson DW; Blajchman MA
    Transfusion; 1995 Sep; 35(9):723-6. PubMed ID: 7570930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Ca2+ homeostasis in Trypanosoma cruzi by crystal violet.
    Docampo R; Gadelha FR; Moreno SN; Benaim G; Hoffmann ME; Vercesi AE
    J Eukaryot Microbiol; 1993; 40(3):311-6. PubMed ID: 8508168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and preservation of fresh and stored erythrocytes in blood treated with gentian violet.
    Moraes-Souza H; Kerbauy J; Barretto OC; Pühler GM; Nonoyama K; Juliano Y
    Braz J Med Biol Res; 1988; 21(2):241-6. PubMed ID: 3144400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi.
    Docampo R; Moreno SN
    Rev Infect Dis; 1984; 6(2):223-38. PubMed ID: 6328615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoquinolone WR6026 as a feasible substitute for gentian violet in Chagas' disease prophylaxis in preserved blood for transfusional purposes.
    Moraes-Souza H; Pianetti GM; Barretto OC; Nonoyama K; Grolg M; Chiari E
    Rev Soc Bras Med Trop; 2002; 35(6):563-9. PubMed ID: 12612735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening in vitro of natural products against blood forms of Trypanosoma cruzi.
    Chiari E; de Oliveira AB; Raslan DS; Mesquita AA; Tavares KG
    Trans R Soc Trop Med Hyg; 1991; 85(3):372-4. PubMed ID: 1949141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protein synthesis and amino acid transport by crystal violet in Trypanosoma cruzi.
    Hoffmann ME; Jang J; Moreno SN; Docampo R
    J Eukaryot Microbiol; 1995; 42(3):293-7. PubMed ID: 7496387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.